Parenteral Iron Therapy: Examining Current Evidence for Use in Athletes

 

 Permissions and Reprints

Abstract

A high prevalence of iron deficiency exists in athlete populations. Various mechanisms, including increased losses through sweat, haemolysis, haematuria, and gastrointestinal micro-ischemia; inadequate dietary intake; and transient exercise-induced increases in the regulatory hormone, hepcidin, contribute to the increased prevalence in athletes. Indeed, hepcidin has been shown to peak around 3–6 hours post-exercise, limiting iron absorption from the gut. As the practitioner’s ability to control losses is limited, the key to treatment of iron deficiency in athletes is optimal timing of dietary and oral iron supplementation around these periods of reduced gut absorption. While timing and dosing schedule strategies might be sufficient to treat iron deficiency non-anaemia, the significant lag to impact iron status is relatively long. Therefore, in iron deficiency anaemia, the use of parenteral iron has the benefit of rapid repletion of iron stores and normalisation of haemoglobin status, while bypassing the action of hepcidin at the gut. Furthermore, newer intravenous formulations can be administered as a single total dose over 15–60 min and have a similar safety profile to oral treatment. This review discusses the existing evidence for parenteral iron use in athletes and the unique context for consideration when choosing the parenteral route in this population.

Publication History

Received: 31 August 2023

Accepted: 13 November 2023

Accepted Manuscript online:
14 November 2023

Article published online:
22 December 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 McCormick R, Sim M, Dawson B. et al. Refining treatment strategies for iron deficient athletes. Sports Med 2020; 50: 2111-2123
  CrossrefPubMedGoogle Scholar
• 2 Clénin G, Cordes M, Huber A. et al. Iron deficiency in sports – definition, influence on performance and therapy. Swiss Med Wkly 2015; 145: w14196 DOI: 10.4414/smw.2015.14196.
  CrossrefPubMedGoogle Scholar
• 3 World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 2011 Available from https://www.who.int/publications/i/item/WHO-NMH-NHD-MNM-11.1 Accessed: 10 November 2023
  PubMed
• 4 Peeling P, Blee T, Goodman C. et al. Effect of iron injections on aerobic-exercise performance of iron-depleted female athletes. Int J Sport Nutr Exerc Metab 2007; 17: 221-231 DOI: 10.1123/ijsnem.17.3.221.
  CrossrefPubMedGoogle Scholar
• 5 Galetti V, Stoffel NU, Sieber C. et al. Threshold ferritin and hepcidin concentrations indicating early iron deficiency in young women based on upregulation of iron absorption. eClin Med 2021; 39: 101052 DOI: 10.1016/j.eclinm.2021.101052.
  CrossrefPubMedGoogle Scholar
• 6 World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. 2020 Available from https://www.who.int/publications/i/item/9789240000124. Accessed: 10 November 2023
  PubMed
• 7 Pedlar CR, Whyte GP, Burden R. et al. A case study of an iron-deficient female Olympic 1500-m runner. Int J Sports Physiol Perform 2013; 8: 695-698 DOI: 10.1123/ijspp.8.6.695.
  CrossrefPubMedGoogle Scholar
• 8 Sim M, Garvican-Lewis LA, Cox GR. et al. Iron considerations for the athlete: a narrative review. Eur J Appl Physiol 2019; 119: 1463-1478 DOI: 10.1007/s00421-019-04157-y.
  CrossrefPubMedGoogle Scholar
• 9 Sims ST, Mackay K, Leabeater A. et al. High prevalence of iron deficiency exhibited in internationally competitive, non-professional female endurance athletes–a case study. Int J Environ Res Public Health 2022; 19 DOI: 10.3390/ijerph192416606.
  CrossrefPubMedGoogle Scholar
• 10 Sim M, Garvican-Lewis LA, Cox GR. et al. Iron considerations for the athlete: a narrative review. Eur J Appl Physiol 2019; 119: 1463-1478
  CrossrefPubMedGoogle Scholar
• 11 Tan D, Dawson B, Peeling P. Hemolytic effects of a football-specific training session in elite female players. Int J Sports Physiol Perform 2012; 7: 271-276 DOI: 10.1123/ijspp.7.3.271.
  CrossrefPubMedGoogle Scholar
• 12 Attwell C, McKay A, Sim M. et al. Timing is everything, but does it really matter? Impact of 8-weeks morning versus evening iron supplementation in ballet and contemporary dancers. Eur J Sport Sci 2023; 23: 2275-2282 DOI: 10.1080/17461391.2023.2224285.
  CrossrefPubMedGoogle Scholar
• 13 Parks RB, Hetzel SJ, Brooks MA. Iron deficiency and anemia among collegiate athletes: a retrospective chart review. Med Sci Sports Exerc 2017; 49: 1711-1715 DOI: 10.1249/MSS.0000000000001259.
  CrossrefPubMedGoogle Scholar
• 14 Nicotra D, Arieli R, Redlich N. et al. Iron deficiency and anemia in male and female adolescent athletes who engage in ball games. J Clin Med 2023; 12: 970 DOI: 10.3390/jcm12030970.
  CrossrefPubMedGoogle Scholar
• 15 Peeling P, Dawson B, Goodman C. et al. Athletic induced iron deficiency: new insights into the role of inflammation, cytokines and hormones. Eur J Appl Physiol 2008; 103: 381-391 DOI: 10.1007/s00421-008-0726-6.
  CrossrefPubMedGoogle Scholar
• 16 Peeling P, Sim M, McKay AKA. Considerations for the consumption of vitamin and mineral supplements in athlete populations. Sports Med 2023; DOI: 10.1007/s40279-023-01875-4.
  CrossrefPubMedGoogle Scholar
• 17 Peeling P, Dawson B, Goodman C. et al. Effects of exercise on hepcidin response and iron metabolism during recovery. Int J Sport Nutr Exerc Metab 2009; 19: 583-597 DOI: 10.1123/ijsnem.19.6.583.
  CrossrefPubMedGoogle Scholar
• 18 Barney DE, Ippolito JR, Berryman CE. et al. A prolonged bout of running increases hepcidin and decreases dietary iron absorption in trained female and male runners. J Nutr 2022; 152: 2039-2047 DOI: 10.1093/jn/nxac129.
  CrossrefPubMedGoogle Scholar
• 19 McCormick R, Moretti D, McKay AKA. et al. The Impact of morning versus afternoon exercise on iron absorption in athletes. Med Sci Sports Exerc 2019; 51: 2147-2155 DOI: 10.1249/MSS.0000000000002026.
  CrossrefPubMedGoogle Scholar
• 20 McCormick R, Dreyer A, Dawson B. et al. The effectiveness of daily and alternate day oral iron supplementation in athletes with suboptimal iron status (Part 2). Int J Sport Nutr Exerc Metab 2020; 30: 191-196 DOI: 10.1123/ijsnem.2019-0310.
  CrossrefPubMedGoogle Scholar
• 21 McKay AKA, Anderson B, Peeling P. et al. Iron absorption in highly-trained runners: Does it matter when and where you eat your iron?. Med Sci Sports Exerc 2023; 55: 916-916
  CrossrefPubMedGoogle Scholar
• 22 Schaap CC, Hendriks JC, Kortman GA. et al. Diurnal rhythm rather than dietary iron mediates daily hepcidin variations. Clin Chem 2013; 59: 527-535 DOI: 10.1373/clinchem.2012.194977.
  CrossrefPubMedGoogle Scholar
• 23 Dawson B, Goodman C, Blee T. et al. Iron supplementation: oral tablets versus intramuscular injection. Int J Sport Nutr Exerc Metab 2006; 16: 180-186 DOI: 10.1123/ijsnem.16.2.180.
  CrossrefPubMedGoogle Scholar
• 24 Garvican LA, Saunders PU, Cardoso T. et al. Intravenous iron supplementation in distance runners with low or suboptimal ferritin. Med Sci Sports Exerc 2014; 46: 376-385 DOI: 10.1249/MSS.0b013e3182a53594.
  CrossrefPubMedGoogle Scholar
• 25 Pasricha SR, Tye-Din J, Muckenthaler MU. et al. Iron deficiency. Lancet 2021; 397: 233-248 DOI: 10.1016/s0140-6736(20)32594-0.
  CrossrefPubMedGoogle Scholar
• 26 Snook J, Bhala N, Beales ILP. et al. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut 2021; 70: 2030-2051 DOI: 10.1136/gutjnl-2021-325210.
  CrossrefPubMedGoogle Scholar
• 27 Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet 2007; 369: 1502-1504
  CrossrefPubMedGoogle Scholar
• 28 Fensham NC, McKay AKA, Tee N. et al. Sequential submaximal training in elite male rowers does not result in amplified increases in interleukin-6 or hepcidin. Int J Sport Nutr Exerc Metab 2022; 32: 177-185 DOI: 10.1123/ijsnem.2021-0263.
  CrossrefPubMedGoogle Scholar
• 29 Girelli D, Ugolini S, Busti F. et al. Modern iron replacement therapy: clinical and pathophysiological insights. Int J Hematol 2018; 107: 16-30 DOI: 10.1007/s12185-017-2373-3.
  CrossrefPubMedGoogle Scholar
• 30 Nikravesh N, Borchard G, Hofmann H. et al. Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: from production to clinical practice. Nanomedicine: NBM 2020; 26: 102178 DOI: 10.1016/j.nano.2020.102178.
  CrossrefPubMedGoogle Scholar
• 31 Auerbach M, Gafter-Gvili A, Macdougall I. Intravenous iron: a framework for changing the management of iron deficiency. Lancet Haematol 2020; 7: e342-e350 DOI: 10.1016/S2352-3026(19)30264-9.
  CrossrefPubMedGoogle Scholar
• 32 National Blood Authority Australia. Iron product choice and dose calculation for adults (2016); Available from: https://blood.gov.au/iron-product-choice-and-dose-calculation-guide-adults Accessed: 10 November 2023
  PubMed
• 33 Garg M, Morrison G, Friedman A. et al. A rapid infusion protocol is safe for total dose iron polymaltose: time for change. Int Med J 2011; 41: 548-554 DOI: 10.1111/j.1445-5994.2010.02356.x.
  CrossrefPubMedGoogle Scholar
• 34 Newnham E, Ahmad I, Thornton A. et al. Safety of iron polymaltose given as a total dose iron infusion. Int Med J 2006; 36: 672-674 DOI: 10.1111/j.1445-5994.2006.01156.x.
  CrossrefPubMedGoogle Scholar
• 35 Karim S, Butler JM, Barclay ML. A 1 g dose of intravenous iron is sufficient to treat iron deficiency anaemia. Int Med J 2020; 50: 1563-1566 DOI: 10.1111/imj.15110.
  CrossrefPubMedGoogle Scholar
• 36 Wang C, Graham DJ, Kane RC. et al. Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA 2015; 314: 2062-2068
  CrossrefPubMedGoogle Scholar
• 37 Bannow BS. In older adults, iron dextran and ferumoxytol each had higher anaphylaxis risk at≤1 d than iron sucrose. Annals Internal Med 2022; 175: JC95
  CrossrefPubMedGoogle Scholar
• 38 Avni T, Bieber A, Grossman A. et al. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc 2015; 90: 12-23 DOI: 10.1016/j.mayocp.2014.10.007.
  CrossrefPubMedGoogle Scholar
• 39 DeLoughery TG. Safety of oral and intravenous iron. Acta Haematol 2019; 142: 8-12
  CrossrefPubMedGoogle Scholar
• 40 Australian Institute of Sport. Iron deficiency best practice guidelines (2022). Available from: https://www.ais.gov.au/__data/assets/pdf_file/0014/1000490/Sport-supplement-fact-sheets-Iron-v4.pdf Accessed: 10 November 2023
  PubMed
• 41 Blunden RW, Lloyd JV, Rudzki Z. et al. Changes in serum ferritin levels after intravenous iron. Ann Clin Biochem 1981; 18: 215-217 DOI: 10.1177/000456328101800405.
  CrossrefPubMedGoogle Scholar
• 42 Garbowski MW, Bansal S, Porter JB. et al. Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways. Haematologica 2021; 106: 2885-2896 DOI: 10.3324/haematol.2020.250803.
  CrossrefPubMedGoogle Scholar
• 43 Neef V, Baumgarten P, Noone S. et al. The impact of timing of intravenous iron supplementation on preoperative haemoglobin in patients scheduled for major surgery. Blood Transfus 2022; 20: 188-197 DOI: 10.2450/2021.0058-21.
  CrossrefPubMedGoogle Scholar
• 44 Klein AA, Chau M, Yeates JA. et al. Preoperative intravenous iron before cardiac surgery: a prospective multicentre feasibility study. Br J Anaesth 2020; 124: 243-250 DOI: 10.1016/j.bja.2019.11.023.
  CrossrefPubMedGoogle Scholar
• 45 Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG 2006; 113: 1248-1252 DOI: 10.1111/j.1471-0528.2006.01062.x.
  CrossrefPubMedGoogle Scholar
• 46 Khalafallah AA, Hyppa A, Chuang A. et al. A prospective randomised controlled trial of a single intravenous infusion of ferric carboxymaltose vs single intravenous iron polymaltose or daily oral ferrous sulphate in the treatment of iron deficiency anaemia in pregnancy. Semin Hematol 2018; 55: 223-234 DOI: 10.1053/j.seminhematol.2018.04.006.
  CrossrefPubMedGoogle Scholar
• 47 Gasche C, Berstad A, Befrits R. et al. Guidelines on the diagnosis and management of iron deficiency and anemia in. inflammatory bowel diseases. Inflam Bowel Dis 2007; 13: 1545-1553 DOI: 10.1002/ibd.20285.
  CrossrefPubMedGoogle Scholar
• 48 Otto JM, Montgomery HE, Richards T. Haemoglobin concentration and mass as determinants of exercise performance and of surgical outcome. Extrem Physiol Med 2013; 2: 33 DOI: 10.1186/2046-7648-2-33.
  CrossrefPubMedGoogle Scholar
• 49 Schmidt W, Prommer N. The optimised CO-rebreathing method: a new tool to determine total haemoglobin mass routinely. Eur J Appl Physiol 2005; 95: 486-495 DOI: 10.1007/s00421-005-0050-3.
  CrossrefPubMedGoogle Scholar
• 50 Burden RJ, Pollock N, Whyte GP. et al. Effect of intravenous iron on aerobic capacity and iron metabolism in elite athletes. Med Sci Sports Exerc 2015; 47: 1399-1407 DOI: 10.1249/MSS.0000000000000568.
  CrossrefPubMedGoogle Scholar
• 51 Woods A, Garvican-Lewis LA, Saunders PU. et al. Four weeks of IV iron supplementation reduces perceived fatigue and mood disturbance in distance runners. PLoS One 2014; 9: e108042 DOI: 10.1371/journal.pone.0108042.
  CrossrefPubMedGoogle Scholar
• 52 Garvican LA, Lobigs L, Telford R. et al. Haemoglobin mass in an anaemic female endurance runner before and after iron supplementation. Int J Sports Physiol Perform 2011; 6: 137-140 DOI: 10.1123/ijspp.6.1.137.
  CrossrefPubMedGoogle Scholar
• 53 McKay AKA, Goods PSR, Binnie MJ. et al. Examining the decay in serum ferritin following intravenous iron infusion: a retrospective cohort analysis of Olympic sport female athletes. Appl Physiol Nutr Metab 2020; 45: 1174-1177 DOI: 10.1139/apnm-2020-0132.
  CrossrefPubMedGoogle Scholar
• 54 World Anti-Doping Agency. Intravenous infusions and/or injections (2023). Available from: https://www.wada-ama.org/sites/default/files/2023-10/tue_physician_guidelines_iv_infusion_october_2023.pdf Accessed: 10 November 2023
  PubMed
• 55 Stellingwerff T, Peeling P, Garvican-Lewis LA. et al. Nutrition and altitude: strategies to enhance adaptation, improve performance and maintain health: a narrative review. Sports Med 2019; 49: 169-184 DOI: 10.1007/s40279-019-01159-w.
  CrossrefPubMedGoogle Scholar
• 56 Garvican-Lewis LA, Vuong VL, Govus AD. et al. Intravenous iron does not augment the hemoglobin mass response to simulated hypoxia. Med Sci Sports Exerc 2018; 50: 1669-1678 DOI: 10.1249/mss.0000000000001608.
  CrossrefPubMedGoogle Scholar
• 57 World Health Organization. Anaemia (2023); Available from: https://www.who.int/health-topics/anaemia#tab=tab_1 Accessed: 10 November 2023
  PubMed
• 58 Tran K, McCormack S. Screening and treatment of obstetric anemia: a review of clinical effectiveness, cost-effectiveness, and guidelines. In: Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. 2019
  PubMedGoogle Scholar
• 59 Govindappagari S, Burwick RM. Treatment of iron deficiency anemia in pregnancy with intravenous versus oral iron: systematic review and meta-analysis. Am J Perinatol 2019; 36: 366-376 DOI: 10.1055/s-0038-1668555.
  Article in Thieme ConnectPubMedGoogle Scholar
• 60 Christoph P, Schuller C, Studer H. et al. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. J Perinat Med 2012; 40: 469-474 DOI: 10.1515/jpm-2011-0231.
  CrossrefPubMedGoogle Scholar